Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01140152 · ClinicalTrials.gov registry record
Proteomic Analysis Reveals Innate Immune Activity In Intestinal Transplant Dysfunction
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 17
- Enrollment target
NCT01140152: Completed study, sponsored by University of California, Los Angeles.
NCT01140152 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01140152 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
Many patients with intestinal failure require intestinal transplantation for survival. Currently, the gold standard for diagnosing acute cellular rejection (ACR) is histological examination of endoscopic biopsies, which are taken invasively and lack sensitivity. A non-invasive method of monitoring for ACR is needed.
Primary Outcome
Protocol biopsies of the transplanted intestine are obtained during endoscopy and when clinical symptoms indicating abnormal allograft function are present. Biopsies were sent to pathology, where the pathologist determined if there was acute rejection. Ostomy effluent taken during times of endoscopy were subjected to MALDI and Luminex technology to look for any proteins or cytokines differentially expressed during rejection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2008-07 |
| Est. Completion | 2009-09 |
What the finished NCT01140152 record still lists
NCT01140152 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01140152 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01140152 about?
NCT01140152 is a clinical study titled "Proteomic Analysis Reveals Innate Immune Activity In Intestinal Transplant Dysfunction". Many patients with intestinal failure require intestinal transplantation for survival. Currently, the gold standard for diagnosing acute cellular rejection (ACR) is histological examination of endoscopic biopsies, which are taken invasively and lack sensitivity. A non-invasive method of monitoring f...
What is the current status of trial NCT01140152?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2008-07. Estimated completion is 2009-09.
Who is sponsoring clinical trial NCT01140152?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia